Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of PPIs on Dabigatran Pharmacokinetics (BIPP)
NCT02524210Phase 1Completed
- Sponsor
- CHU Saint-Etienne
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dabigatran in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (3 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Area under the curve at 24 hours. Started May 2014; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02524210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02524210.